Can nanozymes make the leap to the clinic? Advances, hurdles, and prospects
Trends in Biotechnology · 2026-10 · 44 (10) · 2870-2890
DOI: 10.1016/j.tibtech.2025.12.028 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Biotechnology, 2026-10. Verfasst von Nil K Pandey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Biofilm Research Labs, Levy Center for Oral …. Hauptthemen laut MEDLINE: Nanostructures, Enzymes. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, National Institute of Dental and Craniofacial Research, National Institutes of Health.
Abstract (Originalsprache)
Nanozymes (enzyme-like catalytic nanomaterials) represent a new generation of artificial enzymes designed to overcome key limitations of their natural counterparts, including high production costs, low stability, and challenging storage requirements. Their versatility spans biosensing, bioimaging, therapeutics, and environmental remediation, attracting widespread interest across disciplines. Recent advances have moved nanozymes beyond benchtop proof of concept, with multiple in vivo studies and early clinical investigations demonstrating their translational potential. However, progress toward the clinic remains constrained by limited mechanistic understanding under physiologically relevant conditions; concerns over safety, biodegradability, and long-term efficacy; and uncertainties in scalable manufacturing, market feasibility, and regulatory approval. This review highlights recent breakthroughs in biomedical nanozymes and identifies key knowledge gaps that must be addressed to accelerate successful clinical translation and commercialization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Biofilm Research Labs, Levy Center for Oral Health, School of Dental Medicine, University of Pennsylvania, Philade…
- Biofilm Research Labs, Levy Center for Oral Health, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Orthodontics, Pediatric and Community Oral Health, School of Dental Medicin…
- Biofilm Research Labs, Levy Center for Oral Health, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Mechanical Engineering and Applied Mechanics, School of Engineering and App…
- Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia,…
Förderung
- NIDCR NIH HHS
- National Institute of Dental and Craniofacial Research
- National Institutes of Health
Zitieren
APA
Pandey, N. K., Tran, H. H., Steager, E. B., Cormode, D. P., & Koo, H. (2026). Can nanozymes make the leap to the clinic? Advances, hurdles, and prospects. Trends in Biotechnology, 44(10), 2870-2890. https://doi.org/10.1016/j.tibtech.2025.12.028
Vancouver
Pandey NK, Tran HH, Steager EB, Cormode DP, Koo H. Can nanozymes make the leap to the clinic? Advances, hurdles, and prospects. Trends in Biotechnology. 2026;44(10):2870-2890. doi:10.1016/j.tibtech.2025.12.028
BibTeX
@article{Pandey2026,
author = {Pandey, Nil K and Tran, Hong Huy and Steager, Edward B and Cormode, David P and Koo, Hyun},
title = {Can nanozymes make the leap to the clinic? Advances, hurdles, and prospects},
journal = {Trends in Biotechnology},
year = {2026},
volume = {44},
number = {10},
pages = {2870--2890},
doi = {10.1016/j.tibtech.2025.12.028}
}
EUVIMED